Skip to main content

Nutrition/Obesity

ICYMI:Food for Thought: "ITIS" Diet for Patients with Rheumatoid Arthritis: Dr. Akhil Sood ( @AkhilSoodMD) discusses abstract #1699 presented at the ACR21 annual meeting.https://t.co/bpQuzDGXCF https://t.co/9e2dYddsIx
Dr. John Cush @RheumNow( View Tweet )
Nov 29, 2021
bathroom scale

The Influence of Obesity on Choice of Biologic in Rheumatoid Arthritis

In rheumatoid arthritis we have a wide range of options available to us when we progress to a biologic treatment option. We have little to differentiate between these agents based on the clinical trials. We often make our choices based on minor hints from clinical features, comorbidities, or

Read Article
RheumNow Podcast square

RheumNow Podcast - ACR 2021 Rehash (the good stuff..)

Nov 12, 2021

The ACR 2021 meeting has concluded. Dr. Jack Cush recounts a few more great abstracts from this past week’s virtual meeting.

Read Article
heart2.ekg_.red_.jpg

RA: Cardiovascular Risk Stratification and Potential Predictors of Risk

Early cardiovascular disease assessment and management is critical at diagnosis in patients with Rheumatoid Arthritis (RA). Patients with RA have a known increased risk of developing cardiovascular disease (CVD) due to a higher incidence of traditional cardiovascular (CV) risks such as

Read Article
Dr. Lane on Ca/Vitamin D in Osteoporosis ⭐️🎯serum vitamin D 25OH ~38 ⭐️Studies since 2008 Auckland Calcium trial DO NOT support incr CV risk with Ca supplementation ⭐️Ca calculator: https://t.co/PLPMfZdIwb⭐️No sig change in fracture risk with supp #ACR21 #ACRAmbassador https://t.co/KUa52vf4gT
Veena Katikineni @VeenaRheumMD( View Tweet )
Nov 09, 2021
#ACR21 Ab#1699: ITIS diet: ⭐️Fatigue ⬇️ in 20 pts on ITIS trial, didn't correlate with final DAS28CRP ⭐️Fatigue responders (50% improvement) had different fecal microbiome changes & anti-inflamm compounds, than non-responders @Rheumnow https://t.co/UvE2ZpxCDU
Nov 09, 2021
Dr Coras on "ITIS" anti-inflammatory diet in RA. Improves fatigue after 2 weeks. Fatigue response dissociated from disease activity response. Open label, but promising. Fatigue remains one of our biggest challenges in RA. Abstr#1699 #ACR21 @RheumNow @ElenaNikiUK https://t.co/tBMqmWAy8m
Richard Conway @RichardPAConway( View Tweet )
Nov 09, 2021
My article on the potential use of BMI to guide biologic selection in RA. Discussing #ACR21 abstract 0588 by @MilenaGianfran @JYazdanyMD https://t.co/hxliSZ3IBS @RheumNow

Richard Conway @RichardPAConway( View Tweet )

Nov 09, 2021
The Influence of Obesity on Choice of Biologic Agent in Rheumatoid Arthritis Dr. Richard Conway ( @RichardPAConway) reviews an abstract presented at #ACR21.https://t.co/PkJmpODz8v https://t.co/zuJjofka3B
Dr. John Cush @RheumNow( View Tweet )
Nov 09, 2021
Cush ACR learning computer online

Day 2 Report from ACR21

Nov 08, 2021

This report highlights the VITAL trial; the ORAL Surveillance Study; and the Microbiome study of monozygotic psoriasis patients.

Read Article
Lianne Gensler presenting "Exercise Strategies for Ankylosing Spondylitis". Not all physical activity is similarly beneficial. Learn more now by attending her session at #ACR21! @CherylKoehn @ArthritisNetwrk @EIM_Canada @exerciseworks @PhysioKTBroker @jwhittak_physio @JasminKMa https://t.co/rER3EdCohO
Nov 08, 2021
@LianneGensler Is exercise anti-inflammatory? In this study, healthy volunteers were infused with E coli endotoxin 😲 and their TNF levels measured. TNF levels were compared between groups at rest and groups exercising. TNF levels were ⬇ by exercise. #ACR21 https://t.co/Ylw7SQX32y
Rheum Cat @rheum_cat( View Tweet )
Nov 08, 2021
Physical exercise did not increase BME disease in SIJ and spine in PsA. The risk of increased BME after 11 weeks of HIIT was not higher compared to controls in a cohort of PsA patients with low to moderate disease activity @RheumNow #ACR21 Abst#1362 https://t.co/DHj4D5Ojb1 https://t.co/J4KV5zdpey
Dr. Antoni Chan @synovialjoints( View Tweet )
Nov 08, 2021
Waist:Hip ratio may be better than BMI in screening for obesity in #axSpA accdg to this study by @Sineadm15 & colleagues 👉⬆ prevalence of abdominal obesity in axSpA esp among ♀️ @RheumNow #ACR21 abs1322 https://t.co/UB3K7xR9kG
Nov 08, 2021
ACR Best

ACR21 Best Abstracts - Day 2

Nov 07, 2021

The RheumNow faculty reporters have been scouring and reporting on the best abstracts from the ACR. Here is a sampling of their choice abstract presentations reported during ACR 2020 Day 2 (#ACRbest).

Read Article
#ACR21 #Abstr0864 How does obesity (BMI=/>30) affect #lupus outcomes? Data from Toronto showed: 💠⬆️hs-CRP 💠No in disease activity over 3yrs 💠⬆️CV events (combination of low grade inflammation + hypertension) @RheumNow https://t.co/IBu8uNSAJi https://t.co/2aqz5e3rwi
Md Yuzaiful Md Yusof @Yuz6Yusof( View Tweet )
Nov 07, 2021
🌞😎🍣 Vitamin D and Omega-3 FA ⬇️ Risk of developing autoimmune disease 1st prospective, randomized, double blind, placebo controlled trial Vit D 2000IU and/or Omega 3-FA 1000mg ⬇️autoimmune disease by 25-30% #ACR21 #ACRBest @RheumNow Abs#957https://t.co/7dODuplg7e https://t.co/GUKhYXbSXU
Robert B Chao, MD @doctorRBC( View Tweet )
Nov 07, 2021
To add numbers to this - using ARR because it's easiest: Vitamin D: 123/12,937 = 0.95% rheum dx Placebo: 155/12,937 = 1.20% rheum dx ARR = 0.25% or NNT of 400 to prevent 1 case of rheum dx Better get prescribing ASAP!

Mike Putman @EBRheum( View Tweet )

Nov 07, 2021
#ACR21 #ACRAmbassador Fascinating analysis of rheum dx from the (negative!) VITAL study (https://t.co/aMtMCIf1F1) Very few pts 278/25,871 (1.1%) but HR 0.78, p = 0.045 for vitamin D preventing autoimmune disease Do you believe it? If so, what's your public policy advice? https://t.co/ZkO5nHAJz9
Mike Putman @EBRheum( View Tweet )
Nov 07, 2021
Supplementation for 5 years with vitamin D3 +/- n-3 fatty acids reduced incident autoimmune disease by 25-30% in older adults vs. those who received neither supplement. The effect of vitamin D3 appeared stronger after 2 years @RheumNow #ACR21 Abst#0957 https://t.co/uOwNyjxEoG https://t.co/S5kIM4kj6L
Dr. Antoni Chan @synovialjoints( View Tweet )
Nov 07, 2021
Can vit D, omega-3 fatty acids prevent autoimmune dx development, even in non-deficient people? (some plausibility, no other meds can) vit D *might* have an effect, esp post-2y cautious interest seems okay! extension worth looking at VITAL trial add-on #ACR21 ABST0957 @RheumNow https://t.co/H5aF8Vl79u
Nov 07, 2021
I honestly find Vit D literature confusing! VITAL RCT omega3 and vit D in preventing autoimmune diseases. They seems to work?🧐The confidence intervals just shy of 1.00...I am still skeptical..but keeping vit D normal doesnt hurt I guess....#ACR21 @rheumnow abst#0957 https://t.co/QFcz2zK4Ic
Bella Mehta @bella_mehta( View Tweet )
Nov 07, 2021
Always one of my favourite sessions at #ACR21- #Rheumatology #SecretsAndPearls Dr Kolfenbach reminds us of the importance of discussing #lifestyle, #smoking and #diet with our patients in clinic. @RheumNow #InflammatoryArthritis #RheumatoidArthritis #PsA https://t.co/2gadRBLCTb
Mrinalini Dey @DrMiniDey( View Tweet )
Nov 07, 2021
VITAL RCT of Omega-3 and Vit D in preventing autoimmune diseases in 25,871 individuals. They both work! Reducing incident autoimmune disease by 25-30%. This is game-changing! Abstr#0957 #ACR21 @RheumNow #ACRBest https://t.co/BaeZDTTnQf
Richard Conway @RichardPAConway( View Tweet )
Nov 07, 2021
Obesity does not affect #SLE disease activity despite persistent ⬆️in CRP. From Toronto #lupus database #ACR21 abst#0864 @RheumNow https://t.co/4ZpAMaU0jk
Nov 07, 2021
×